Monday Dec 2
Investors Buy High Volume of Ironwood Pharmaceuticals Put Options
Shares of Ironwood Pharmaceuticals saw some unusual options trading on Friday. Stock investors purchased 1,028 put options on the stock, AnalystRatings.NET reports.
Ironwood Pharmaceuticals to Host Investor Day on December 12, 2013
Ironwood Pharmaceuticals, Inc. will host a live webcast of its Investor Day, which is being held on Thursday, December 12, 2013 beginning at 8:30 a.m. ET in New York City.
Ironwood Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference
Ironwood Pharmaceuticals, Inc. will present a corporate update at the Credit Suisse 2013 Healthcare Conference on Tuesday, November 12, 2013 at 3:30 p.m. Mountain Time/5:30 p.m. Eastern Time.
Nothing Should Irritate You About Synergy's Upcoming Catalysts
Synergy Pharmaceuticals is a biotechnology company whose leading developmental drug is being developed for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation .
Ironwood Pharmaceuticals Given New $11.00 Price Target at Jefferies Group
The firm currently has a "hold" rating on the stock. Jefferies Group's price objective indicates a potential upside of 9.67% from the stock's previous close.